Can a drug tame antipsychotic hormone side effects without worsening symptoms?
NCT ID NCT07386080
First seen Feb 04, 2026 · Last updated May 13, 2026 · Updated 13 times
Summary
This study looks at whether cabergoline is safe for people with schizophrenia who have high prolactin levels from their antipsychotic medication. About 146 adults will take either cabergoline or a placebo for 12 weeks. Researchers will check if the drug affects their schizophrenia symptoms compared to placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zealand University Hospital
Køge, Region Sjælland, 4600, Denmark
Conditions
Explore the condition pages connected to this study.